Cancer Research & Treatment Fund Inc

Analysis

Cancer Research & Treatment Fund Inc is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in June 1968, 58 years ago. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Cancer Research & Treatment Fund Inc reported income of $1.0m and spending of $1.0m, spending 99% of its income. Across the 5 years on record, from December 2019 to December 2023, income fell from $1.2m to $1.0m (-16%), an average of -4.4% a year. The sharpest change came in the year to December 2023, when income rose by 79%. Over the whole period it spent 89% of the income it received.

Among 72,936 United States charities whose main cause is other charitable purposes and that reported income, Cancer Research & Treatment Fund Inc sits at the 78th percentile: it is larger than about 78% of them. Against every charity in United States with reported income it ranks in the 80th percentile, and in the 76th percentile within NY. Charities of a similar size with the same main cause include West Hartford Fellowship Housing in ($1.0m), Starrs Watchful Eye Inc ($1.0m) and Besser Museum of Northeast Michigan Inc ($1.0m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 75% of the total. Compensation of current officers, directors and key employees was $120k (12% of expenses). Other salaries and wages came to $143k. At year end it held assets of $13.7m against liabilities of $356k, net assets of $13.4m. It reported 3 employees.